Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 11/2017

01-11-2017 | Original Article

GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4+ T lymphocyte count

Authors: Bárbara Katharine Barbosa de Miranda, Keyla Santos Guedes de Sá, Andrea Nazaré Rangel da Silva, Rosimar Neris Martins Feitosa, Izaura Maria Vieira Cayres-Vallinoto, Ricardo Ishak, Antonio Carlos Rosário Vallinoto

Published in: Archives of Virology | Issue 11/2017

Login to get access

Abstract

GB virus C (GBV-C) is a lymphotropic virus with a low level or non-existent replication in the liver. The interaction between HIV-1 and GBV-C apparently reduces the progression of HIV-1 infection to AIDS and improves the quality of life of HIV-1 infected individuals. A cross-sectional study was established to determine the possible effect of HIV-1/GBV-C coinfection on HIV-1 viral load and CD4+ T lymphocyte counts. Samples from 313 HIV-1 infected persons from the Virus Laboratory of the Federal University of Pará as well as demographic and clinical information were obtained from medical records. This study used a nested PCR method to determine GBV-C viremia. The prevalence of HIV-1/GBV-C coinfection was 17%. There were no significant differences in the distribution according to age, sex or ethnicity between the groups. The differences in HIV-1 viral load and CD4+ T lymphocyte count between the HIV-1 and HIV-1/GBV-C groups were highly significant, indicating that coinfection results in lower viral loads and higher CD4+ T lymphocyte counts compared to HIV-1 mono-infection. The results indicate a protective effect among coinfected individuals.
Literature
1.
Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG et al (1995) Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 92:3401–3405CrossRefPubMedPubMedCentral
2.
Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H et al (1996) Molecular cloning and disease association of Hepatitis G virus: a transfusion-transmissible agent. Science 271:505–508CrossRefPubMed
3.
Alter HJ (1996) The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 334:1536–1537CrossRefPubMed
4.
Tucker TJ, Smuts HE (2001) Review of the epidemiology, molecular characterization and tropism of the hepatitis G virus/GBV-C. Clin Lab 47:239–248PubMed
5.
AbuOdeh RO, Al-Absi E, Ali NH, Khalili M, Al-Mawlawi N, Hadwan TA et al (2015) Detection and phylogenetic analysis of human pegivirus (GBV-C) among blood donors and patients infected with Hepatitis B virus (HBV) in Qatar. J Med Virol 87:2074–2081CrossRefPubMed
6.
Odeh RA, Yasin S, Nasrallah G, Babi Y (2010) Rates of infection and phylogenetic analysis of GB virus-C among Kuwaiti and Jordanian blood donors. Intervirology 53:402–407CrossRefPubMed
7.
Supapol WB, Remis RS, Raboud J, Millson M, Tappero J, Kaul R et al (2011) Prevalence and correlates of GB virus C infection in HIV-infected and HIV-uninfected pregnant women in Bangkok, Thailand. J Med Virol 83:33–44CrossRef
8.
Liu Z, Li L, Chen Z, Xu M, Zhang T, Jiao Y et al (2012) Prevalence of GB virus type C viraemia in MSM with or without HIV-1 infection in Beijing, China. Epidemiol Infect 140:2199–2209CrossRefPubMed
9.
Rodriguez AK, Garzaro DJ, Loureiro CL, Gutierrez CR, Ameli G, Jaspe RC et al (2014) HIV-1 and GBV-C co-infection in Venezuela. J Infect Dev Ctries 8:863–868CrossRefPubMed
10.
Alcalde R, Nishiya A, Casseb J, Inocencio L, Fonseca LA, Duarte AJ (2010) Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy. Virus Res 151:148–152CrossRefPubMed
11.
Keys JR, Leone PA, Eron JJ, Alexander K, Brinson M, Swanstrom R (2014) Large scale screening of human sera for HCV RNA and GBV-C RNA. J Med Virol 86:473–477CrossRefPubMed
12.
Blackard JT, Ma G, Welge JA, King CC, Taylor LE, Mayer KH et al (2014) GB virus C (GBV-C) infection in Hepatitis C virus (HCV) seropositive women with or at risk for HIV infection. PLoS One 9:e114467CrossRefPubMedPubMedCentral
13.
Claret G, Noguera A, Gonzalez-Cuevas A, Garcia-Garcia JJ, Fortuny C, Munoz-Almagro C (2008) The prevalence of GB virus C/Hepatitis G virus RNA among healthy and HCV-infected Catalan children. Eur J Pediatr 167:991–994CrossRefPubMed
14.
Tenckhoff S, Kaiser T, Bredeek F, Donfield S, Menius E, Lail A et al (2012) Role of GB virus C in human immunodeficiency virus type-1- and Hepatitis C virus-infected hemophiliac children and adolescents. J Acquir Immune Defic Syndr 61:243–248CrossRefPubMed
15.
Muerhoff AS, Dawson GJ, Desai SM (2006) A previously unrecognized sixth genotype of GB virus C revealed by analysis of 5′-untranslated region sequences. J Med Virol 78:105–111CrossRefPubMed
16.
Smith DB, Cuceanu N, Davidson F, Jarvis LM, Mokili JL, Hamid S et al (1997) Discrimination of Hepatitis G virus/GBV-C geographical variants by analysis of the 5′ non-coding region. J Gen Virol 78:1533–1542CrossRefPubMed
17.
Muerhoff AS, Leary TP, Sathar MA, Dawson GJ, Desai SM (2005) African origin of GB virus C determined by phylogenetic analysis of a complete genotype 5 genome from South Africa. J Gen Virol 86:1729–1735CrossRefPubMed
18.
Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT (2006) Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians. HIV Med 7:25–31CrossRefPubMed
19.
Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC et al (2001) Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345:715–724CrossRefPubMed
20.
Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C et al (2004) Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350:981–990CrossRefPubMed
21.
Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT (2006) Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Med 7:173–180CrossRefPubMed
22.
Hattori J, Okumura N, Yamazaki Y, Uchiyama M, Hamaguchi M, Nishiyama Y et al (2007) Beneficial effect of GB virus C co-infection in Human Immunodeficiency Virus type 1-infected individuals. Microbiol Immunol 51:193–200CrossRefPubMed
23.
Lefrère JJ, Ferec C, Roudot-Thoraval F, Loiseau P, Cantaloube J, Biagini P et al (1999) GBV-C/Hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals. J Med Virol 59:32–37CrossRefPubMed
24.
Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL et al (2001) Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345:707–714CrossRefPubMed
25.
Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ (2000) Effect of Hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 132:959–963CrossRefPubMed
26.
Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT (2004) Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 363:2040–2046CrossRefPubMed
27.
Jung S, Knauer O, Donhauser N, Eichenmuller M, Helm M, Fleckenstein B et al (2005) Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors. AIDS 19:1267–1272CrossRefPubMed
28.
Nunnari G, Nigro L, Palermo F, Attanasio M, Berger A, Doerr HW et al (2003) Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 139:26–30CrossRefPubMed
29.
Siegal F (2003) Interferon-producing plasmacytoid dendritic cells and the pathogenesis of AIDS. Res Initiat Treat Action 8:10–13PubMed
30.
Capobianchi M, Lalle E, Martini F, Poccia F, D’Offizi G, Antonucci G et al (2006) Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients. Cell Mol Biol 52:3–8PubMed
31.
32.
Ayres M, Ayres M, Ayres D, Santos A (2007) BioEstat 5.0: aplicações estatísticas nas áreas das ciências biológicas e médicas. Instituto de Desenvolvimento Sustentável Mamirauá - IDSM/MCT/CNPq, vol 1. p 364
33.
Rey D, Vidinic-Moularde J, Meyer P, Schmitt C, Fritsch S, Lang JM et al (2000) High prevalence of GB virus C/Hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 19:721–724CrossRefPubMed
34.
Rendina D, Vigorita E, Bonavolta R, D’Onofrio M, Iura A, Pietronigro MT et al (2001) HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. Eur J Epidemiol 17:801–807CrossRefPubMed
35.
Gutierrez RA, Dawson GJ, Knigge MF, Melvin SL, Heynen CA, Kyrk CR et al (1997) Seroprevalence of GB virus C and persistence of RNA and antibody. J Med Virol 53:167–173CrossRefPubMed
36.
Ribeiro-dos-Santos G, Nishiya A, Nascimento C, Bassit L, Chamone D, Focaccia R et al (2002) Prevalence of GB virus C (Hepatitis G virus) and risk factors for infection in Sao Paulo, Brazil. Eur J Clin Microbiol Infect Dis 21:438–443CrossRefPubMed
37.
Levi JE, Contri DG, Lima LP, Takaoka DT, Garrini RH, Santos W et al (2003) High prevalence of GB virus C/Hepatitis G virus RNA among Brazilian blood donors. Rev Inst Med Trop Sao Paulo 45:75–78CrossRefPubMed
38.
Amarante MK, Miranda HC, de Oliveira CEC, de Oliveira KB, Watanabe MAE (2004) Detecção do RNA HGV/GBV-C em indivíduos saudáveis não portadores de HBV, HIV-1/2 e HCV. Semina: Ciências Biológicas e da Saúde 25:39–44
39.
Ramezani A, Mohraz M, Vahabpour R, Jam S, Banifazl M, Eslamifar A et al (2008) Frequency of Hepatitis G virus infection among HIV positive subjects with parenteral and sexual exposure. J Gastrointestin Liver Dis 17:269–272PubMed
40.
Scallan MF, Clutterbuck D, Jarvis LM, Scott GR, Simmonds P (1998) Sexual transmission of GB virus C/hepatitis G virus. J Med Virol 55:203–208CrossRefPubMed
41.
Jarvis L, Davidson F, Hanley J, Yap P, Ludlam C, Simmonds P (1996) Infection with Hepatitis G virus among recipients of plasma products. Lancet 348:1352–1355CrossRefPubMed
42.
Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M et al (2008) Frequency and genotype of GB virus C among Iranian patients infected with HIV. J Med Virol 80:1941–1946CrossRefPubMed
43.
Brasil. Ministério da Saúde, Secretaria de Vigilância em Saúde (2015) Programa nacional de DST e AIDS. Boletim epidemiológico—AIDS
44.
Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H (1998) Effect of GB virus C/Hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 17:209–213CrossRefPubMed
45.
Lefrère JJ, Roudot-Thoraval F, Morand-Joubert L, Petit JC, Lerable J, Thauvin M et al (1999) Carriage of GB virus C/Hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 179:783–789CrossRefPubMed
46.
47.
Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H (2011) Peptides derived from a distinct region of GB Virus C glycoprotein E2 mediate strain specific HIV-1 entry inhibition. J Virol 85:7037–7047CrossRefPubMedPubMedCentral
48.
George SL, Varmaz D, Tavis JE, Chowdhury A (2012) The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression. PLoS One 7:e30653CrossRefPubMedPubMedCentral
49.
Tillmann HL, Manns MP, Claes C, Heiken H, Schmidt RE, Stoll M (2004) GB virus C infection and quality of life in HIV-positive patients. AIDS Care 16:736–743CrossRefPubMed
50.
Ruiz V, Espínola L, Mathet VL, Perandones CE, Oubiña JR (2006) Design, development and evaluation of a competitive RT-PCR for quantitation of GBV-C RNA. J Virol Methods 136:58–64CrossRefPubMed
51.
Mosam A, Sathar MA, Dawood H, Cassol E, Esterhuizen TM, Coovadia HM (2007) Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection. AIDS 21:1377–1379CrossRefPubMed
52.
Li C, Collini P, Danso K, Owusu-Ofori S, Dompreh A, Candotti D, Opare-Sem O, Allain JP (2006) Gb virus C And Hiv-1 Rna load in single virus and co-infected west african individuals. Aids 20:379–386CrossRefPubMed
Metadata
Title
GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4+ T lymphocyte count
Authors
Bárbara Katharine Barbosa de Miranda
Keyla Santos Guedes de Sá
Andrea Nazaré Rangel da Silva
Rosimar Neris Martins Feitosa
Izaura Maria Vieira Cayres-Vallinoto
Ricardo Ishak
Antonio Carlos Rosário Vallinoto
Publication date
01-11-2017
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 11/2017
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3514-y

Other articles of this Issue 11/2017

Archives of Virology 11/2017 Go to the issue

Original Article

Dynamic distribution and tissue tropism of avian encephalomyelitis virus isolate XY/Q-1410 in experimentally infected Korean quail

Original Article

Bioselection of coxsackievirus B6 strain variants with altered tropism to human cancer cell lines

Original Article

Detection of waterborne norovirus genogroup I strains using an improved real time RT-PCR assay

Brief Report

Study of the association between histo-blood group antigens and norovirus infection in Chinese children

Original Article

Profiling of cellular microRNA responses during the early stages of KSHV infection

Original Article

Transmission network characteristics based on env and gag sequences from MSM during acute HIV-1 infection in Beijing, China
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits